{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T13:44:04Z","timestamp":1780321444845,"version":"3.54.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LR20H160001"],"award-info":[{"award-number":["LR20H160001"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LY23H020003"],"award-info":[{"award-number":["LY23H020003"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070275"],"award-info":[{"award-number":["82070275"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Recent studies found that treatment with an anti-T-cell immunoglobulin mucin-1 (TIM1) monoclonal antibody (RMT1-10) regulated immune responses by inducing regulatory B cells (Bregs). However, the role of these cells in myocardial ischemia-reperfusion injury (IRI) is unknown. This study aimed to investigate the protective effect of RMT1-10 on myocardial IRI and its potential mechanism. We established a myocardial IRI model, and Triphenyl tetrazolium chloride staining, Terminal deoxynucleotidyl transferase nick-end-labeling, hematoxylin and eosin, and transmission electron microscopy were performed to examine the myocardial infarction size, myocardial cell apoptosis, and cardiomyocyte morphology and structure. The data showed that RMT1-10 could alleviate myocardial IRI, increase the number of TIM1<jats:sup>+<\/jats:sup>Bregs and interleukin 10 (IL-10) secretion, and regulate the expression of inflammatory factors after myocardial IRI. However, treatment with RMT1-10 and Anti-CD20 abrogated the protective effect of RMT-10. In addition, RMT1-10 treatment inhibited T cells but significantly activated Tregs after IRI, while RMT1-10 combined with Anti-CD20 abolished this effect on Tregs. Furthermore, sequencing analysis showed marked expression changes among genes related to several classical signaling pathways in response to RMT1-10. Taken together, these findings indicated that RMT1-10 could increase the number of TIM1<jats:sup>+<\/jats:sup> Bregs and regulate IL-10-mediated inflammatory reactions, activate Tregs to inhibit inflammation, and might regulate the above-mentioned signaling pathways to protect against myocardial IRI.<\/jats:p>","DOI":"10.1038\/s41420-025-02725-0","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T13:27:17Z","timestamp":1759843637000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The effect of TIM1+ Breg cells in myocardial ischemia-reperfusion injury"],"prefix":"10.1038","volume":"11","author":[{"given":"Cong","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianchuan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjian","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiqiang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7143-7355","authenticated-orcid":false,"given":"Jie","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0399-6216","authenticated-orcid":false,"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dajin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qunjun","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,7]]},"reference":[{"key":"2725_CR1","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10741-019-09831-z","volume":"25","author":"BR Pagliaro","year":"2020","unstructured":"Pagliaro BR, Cannata F, Stefanini GG, Bolognese L. Myocardial ischemia and coronary disease in heart failure. Heart Fail Rev. 2020;25:53\u201365. https:\/\/doi.org\/10.1007\/s10741-019-09831-z.","journal-title":"Heart Fail Rev"},{"key":"2725_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.medj.2023.12.007","volume":"5","author":"G Heusch","year":"2024","unstructured":"Heusch G. Myocardial ischemia\/reperfusion: translational pathophysiology of ischemic heart disease. Med. 2024;5:10\u201331. https:\/\/doi.org\/10.1016\/j.medj.2023.12.007.","journal-title":"Med"},{"key":"2725_CR3","doi-asserted-by":"publisher","first-page":"13541","DOI":"10.1111\/apha.13541","volume":"231","author":"L Ying","year":"2021","unstructured":"Ying L, Benjanuwattra J, Chattipakorn SC, Chattipakorn N. The role of RIPK3-regulated cell death pathways and necroptosis in the pathogenesis of cardiac ischaemia-reperfusion injury. Acta Physiol. 2021;231:13541. https:\/\/doi.org\/10.1111\/apha.13541.","journal-title":"Acta Physiol"},{"key":"2725_CR4","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.tcm.2022.02.005","volume":"33","author":"M Algoet","year":"2023","unstructured":"Algoet M, Janssens S, Himmelreich U, Gsell W, Pusovnik M, Van den Eynde J, et al. Myocardial ischemia-reperfusion injury and the influence of inflammation. Trends Cardiovasc Med. 2023;33:357\u201366. https:\/\/doi.org\/10.1016\/j.tcm.2022.02.005.","journal-title":"Trends Cardiovasc Med"},{"key":"2725_CR5","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.tem.2023.10.010","volume":"35","author":"Q Xiang","year":"2024","unstructured":"Xiang Q, Yi X, Zhu XH, Wei X, Jiang DS. Regulated cell death in myocardial ischemia-reperfusion injury. Trends Endocrinol Metab. 2024;35:219\u201334. https:\/\/doi.org\/10.1016\/j.tem.2023.10.010.","journal-title":"Trends Endocrinol Metab"},{"key":"2725_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-09386-7","volume":"22","author":"L Chen","year":"2022","unstructured":"Chen L, Qing J, Xiao Y, Huang X, Chi Y, Chen Z. TIM-1 promotes proliferation and metastasis, and inhibits apoptosis, in cervical cancer through the PI3K\/AKT\/p53 pathway. BMC Cancer. 2022;22:370. https:\/\/doi.org\/10.1186\/s12885-022-09386-7.","journal-title":"BMC Cancer"},{"key":"2725_CR7","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1465-9921-10-42","volume":"10","author":"F Idali","year":"2009","unstructured":"Idali F, Wahlstr\u00f6m J, Dahlberg B, Khademi M, Olsson T, Eklund A, et al. Altered expression of T cell immunoglobulin-mucin (TIM) molecules in bronchoalveolar lavage CD4+ T cells in sarcoidosis. Respir Res. 2009;10:42. https:\/\/doi.org\/10.1186\/1465-9921-10-42.","journal-title":"Respir Res"},{"key":"2725_CR8","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1098\/rstb.2005.1706","volume":"360","author":"C Mariat","year":"2005","unstructured":"Mariat C, S\u00e1nchez-Fueyo A, Alexopoulos SP, Kenny J, Strom TB, Zheng XX. Regulation of T cell dependent immune responses by TIM family members. Philos Trans R Soc Lond B Biol Sci. 2005;360:1681\u20135. https:\/\/doi.org\/10.1098\/rstb.2005.1706.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"2725_CR9","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/j.1600-6143.2012.04316.x","volume":"13","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Ji H, Shen X, Cai J, Gao F, Koenig KM, et al. Targeting TIM-1 on CD4 T cells depresses macrophage activation and overcomes ischemia-reperfusion injury in mouse orthotopic liver transplantation. Am J Transpl. 2013;13:56\u201366. https:\/\/doi.org\/10.1111\/j.1600-6143.2012.04316.x.","journal-title":"Am J Transpl"},{"key":"2725_CR10","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s12020-019-02173-8","volume":"68","author":"H Guo","year":"2020","unstructured":"Guo H, Shen Y, Kong YH, Li S, Jiang R, Liu C, et al. The expression of Tim-1 and Tim-4 molecules in regulatory T cells in type 1 diabetes. Endocrine. 2020;68:64\u201370. https:\/\/doi.org\/10.1007\/s12020-019-02173-8.","journal-title":"Endocrine"},{"key":"2725_CR11","doi-asserted-by":"publisher","first-page":"3645","DOI":"10.1172\/JCI46274","volume":"121","author":"Q Ding","year":"2011","unstructured":"Ding Q, Yeung M, Camirand G, Zeng Q, Akiba H, Yagita H, et al. Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice. J Clin Invest. 2011;121:3645\u201356. https:\/\/doi.org\/10.1172\/JCI46274.","journal-title":"J Clin Invest"},{"key":"2725_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/imr.12933","volume":"299","author":"A Cherukuri","year":"2021","unstructured":"Cherukuri A, Mohib K, Rothstein DM. Regulatory B cells: TIM-1, transplant tolerance, and rejection. Immunol Rev. 2021;299:31\u201344. https:\/\/doi.org\/10.1111\/imr.12933.","journal-title":"Immunol Rev"},{"key":"2725_CR13","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1046\/j.1523-1747.1998.00218.x","volume":"110","author":"RM Porter","year":"1998","unstructured":"Porter RM, Reichelt J, Lunny DP, Magin TM, Lane EB. The relationship between hyperproliferation and epidermal thickening in a mouse model for BCIE. J Invest Dermatol. 1998;110:951\u20137. https:\/\/doi.org\/10.1046\/j.1523-1747.1998.00218.x.","journal-title":"J Invest Dermatol"},{"key":"2725_CR14","first-page":"3665","volume":"9","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Liu Y, Chen H, Zheng X, Xie S, Chen W, et al. TIM-1 attenuates the protection of ischemic preconditioning for ischemia reperfusion injury in liver transplantation. Am J Transl Res. 2017;9:3665\u201375.","journal-title":"Am J Transl Res"},{"key":"2725_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-019-0417-4","volume":"17","author":"Y Zheng","year":"2019","unstructured":"Zheng Y, Wang L, Chen M, Liu L, Pei A, Zhang R, et al. Inhibition of T cell immunoglobulin and mucin-1 (TIM-1) protects against cerebral ischemia-reperfusion injury. Cell Commun Signal. 2019;17:103. https:\/\/doi.org\/10.1186\/s12964-019-0417-4.","journal-title":"Cell Commun Signal"},{"key":"2725_CR16","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.4049\/jimmunol.1402632","volume":"194","author":"S Xiao","year":"2015","unstructured":"Xiao S, Brooks CR, Sobel RA, Kuchroo VK. Tim-1 is essential for induction and maintenance of IL-10 in regulatory B cells and their regulation of tissue inflammation. J Immunol. 2015;194:1602\u20138. https:\/\/doi.org\/10.4049\/jimmunol.1402632.","journal-title":"J Immunol"},{"key":"2725_CR17","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.4049\/jimmunol.178.6.3447","volume":"178","author":"MK Mann","year":"2007","unstructured":"Mann MK, Maresz K, Shriver LP, Tan Y, Dittel BN. B cell regulation of CD4+CD25+ T regulatory cells and IL-10 via B7 is essential for recovery from experimental autoimmune encephalomyelitis. J Immunol. 2007;178:3447\u201356. https:\/\/doi.org\/10.4049\/jimmunol.178.6.3447.","journal-title":"J Immunol"},{"key":"2725_CR18","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/nature11501","volume":"491","author":"A Yoshizaki","year":"2012","unstructured":"Yoshizaki A, Miyagaki T, DiLillo DJ, Matsushita T, Horikawa M, Kountikov EI, et al. Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions. Nature. 2012;491:264\u20138. https:\/\/doi.org\/10.1038\/nature11501.","journal-title":"Nature"},{"key":"2725_CR19","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.molimm.2014.01.014","volume":"62","author":"EC Rosser","year":"2014","unstructured":"Rosser EC, Blair PA, Mauri C. Cellular targets of regulatory B cell-mediated suppression. Mol Immunol. 2014;62:296\u2013304. https:\/\/doi.org\/10.1016\/j.molimm.2014.01.014.","journal-title":"Mol Immunol"},{"key":"2725_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tcm.2022.09.003","volume":"34","author":"I Rabinovich-Nikitin","year":"2024","unstructured":"Rabinovich-Nikitin I, Kirshenbaum LA. Circadian regulated control of myocardial ischemia-reperfusion injury. Trends Cardiovasc Med. 2024;34:1\u20137. https:\/\/doi.org\/10.1016\/j.tcm.2022.09.003.","journal-title":"Trends Cardiovasc Med"},{"key":"2725_CR21","doi-asserted-by":"publisher","first-page":"102884","DOI":"10.1016\/j.ebiom.2020.102884","volume":"57","author":"CJA Ramachandra","year":"2020","unstructured":"Ramachandra CJA, Hernandez-Resendiz S, Crespo-Avilan GE, Lin YH, Hausenloy DJ. Mitochondria in acute myocardial infarction and cardioprotection. EBioMedicine. 2020;57:102884. https:\/\/doi.org\/10.1016\/j.ebiom.2020.102884.","journal-title":"EBioMedicine"},{"key":"2725_CR22","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13075-016-1213-9","volume":"19","author":"O Aravena","year":"2017","unstructured":"Aravena O, Ferrier A, Menon M, Mauri C, Aguill\u00f3n JC, Soto L, et al. TIM-1 defines a human regulatory B cell population that is altered in frequency and function in systemic sclerosis patients. Arthritis Res Ther. 2017;19:8. https:\/\/doi.org\/10.1186\/s13075-016-1213-9.","journal-title":"Arthritis Res Ther"},{"key":"2725_CR23","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1172\/JCI32451","volume":"118","author":"T Ueno","year":"2008","unstructured":"Ueno T, Habicht A, Clarkson MR, Albin MJ, Yamaura K, Boenisch O, et al. The emerging role of T cell Ig mucin 1 in alloimmune responses in an experimental mouse transplant model. J Clin Invest. 2008;118:742\u201351. https:\/\/doi.org\/10.1172\/JCI32451.","journal-title":"J Clin Invest"},{"key":"2725_CR24","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1146\/annurev-immunol-020711-074934","volume":"30","author":"C Mauri","year":"2012","unstructured":"Mauri C, Bosma A. Immune regulatory function of B cells. Annu Rev Immunol. 2012;30:221\u201341. https:\/\/doi.org\/10.1146\/annurev-immunol-020711-074934.","journal-title":"Annu Rev Immunol"},{"key":"2725_CR25","doi-asserted-by":"publisher","first-page":"981847","DOI":"10.3389\/fimmu.2022.981847","volume":"13","author":"H Moreira","year":"2022","unstructured":"Moreira H, Dobosz A, Cwynar-Zaj\u0105c \u0141, Nowak P, Czy\u017cewski M, Barg M, et al. Unraveling the role of Breg cells in digestive tract cancer and infectious immunity. Front Immunol. 2022;13:981847. https:\/\/doi.org\/10.3389\/fimmu.2022.981847.","journal-title":"Front Immunol"},{"key":"2725_CR26","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.immuni.2014.10.016","volume":"41","author":"M Matsumoto","year":"2014","unstructured":"Matsumoto M, Baba A, Yokota T, Nishikawa H, Ohkawa Y, Kayama H, et al. Interleukin-10-producing plasmablasts exert regulatory function in autoimmune inflammation. Immunity. 2014;41:1040\u201351. https:\/\/doi.org\/10.1016\/j.immuni.2014.10.016.","journal-title":"Immunity"},{"key":"2725_CR27","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.immuni.2015.04.005","volume":"42","author":"EC Rosser","year":"2015","unstructured":"Rosser EC, Mauri C. Regulatory B cells: origin, phenotype, and function. Immunity. 2015;42:607\u201312. https:\/\/doi.org\/10.1016\/j.immuni.2015.04.005.","journal-title":"Immunity"},{"key":"2725_CR28","doi-asserted-by":"publisher","first-page":"611795","DOI":"10.3389\/fimmu.2021.611795","volume":"12","author":"D Catal\u00e1n","year":"2021","unstructured":"Catal\u00e1n D, Mansilla MA, Ferrier A, Soto L, Oleinika K, Aguill\u00f3n JC, et al. Immunosuppressive mechanisms of regulatory B cells. Front Immunol. 2021;12:611795. https:\/\/doi.org\/10.3389\/fimmu.2021.611795.","journal-title":"Front Immunol"},{"key":"2725_CR29","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.immuni.2019.11.014","volume":"52","author":"AR Cillo","year":"2020","unstructured":"Cillo AR, K\u00fcrten C, Tabib T, Qi Z, Onkar S, Wang T, et al. Immune landscape of viral- and carcinogen-driven head and neck cancer. Immunity. 2020;52:183\u2013199.e189. https:\/\/doi.org\/10.1016\/j.immuni.2019.11.014.","journal-title":"Immunity"},{"key":"2725_CR30","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nm.3554","volume":"20","author":"RX Wang","year":"2014","unstructured":"Wang RX, Yu CR, Dambuza IM, Mahdi RM, Dolinska MB, Sergeev YV, et al. Interleukin-35 induces regulatory B cells that suppress autoimmune disease. Nat Med. 2014;20:633\u201341. https:\/\/doi.org\/10.1038\/nm.3554.","journal-title":"Nat Med"},{"key":"2725_CR31","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/nature12979","volume":"507","author":"P Shen","year":"2014","unstructured":"Shen P, Roch T, Lampropoulou V, O'Connor RA, Stervbo U, Hilgenberg E, et al. IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases. Nature. 2014;507:366\u201370. https:\/\/doi.org\/10.1038\/nature12979.","journal-title":"Nature"},{"key":"2725_CR32","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/s41586-022-05254-3","volume":"610","author":"S Li","year":"2022","unstructured":"Li S, Mirlekar B, Johnson BM, Brickey WJ, Wrobel JA, Yang N, et al. STING-induced regulatory B cells compromise NK function in cancer immunity. Nature. 2022;610:373\u201380. https:\/\/doi.org\/10.1038\/s41586-022-05254-3.","journal-title":"Nature"},{"key":"2725_CR33","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/imr.12938","volume":"299","author":"EA Leadbetter","year":"2021","unstructured":"Leadbetter EA, Karlsson MCI. Invariant natural killer T cells balance B cell immunity. Immunol Rev. 2021;299:93\u2013107. https:\/\/doi.org\/10.1111\/imr.12938.","journal-title":"Immunol Rev"},{"key":"2725_CR34","doi-asserted-by":"publisher","first-page":"711980","DOI":"10.3389\/fimmu.2021.711980","volume":"12","author":"SY Yang","year":"2021","unstructured":"Yang SY, Long J, Huang MX, Luo PY, Bian ZH, Xu YF, et al. Characterization of organ-specific regulatory B cells using single-cell RNA sequencing. Front Immunol. 2021;12:711980. https:\/\/doi.org\/10.3389\/fimmu.2021.711980.","journal-title":"Front Immunol"},{"key":"2725_CR35","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/ni833","volume":"3","author":"S Fillatreau","year":"2002","unstructured":"Fillatreau S, Sweenie CH, McGeachy MJ, Gray D, Anderton SM. B cells regulate autoimmunity by provision of IL-10. Nat Immunol. 2002;3:944\u201350. https:\/\/doi.org\/10.1038\/ni833.","journal-title":"Nat Immunol"},{"key":"2725_CR36","doi-asserted-by":"publisher","first-page":"5569","DOI":"10.4049\/jimmunol.1100284","volume":"186","author":"NA Carter","year":"2011","unstructured":"Carter NA, Vasconcellos R, Rosser EC, Tulone C, Mu\u00f1oz-Suano A, Kamanaka M, et al. Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1\/Th17 but a decrease in regulatory T cells. J Immunol. 2011;186:5569\u201379. https:\/\/doi.org\/10.4049\/jimmunol.1100284.","journal-title":"J Immunol"},{"key":"2725_CR37","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/ar3736","volume":"14","author":"NA Carter","year":"2012","unstructured":"Carter NA, Rosser EC, Mauri C. Interleukin-10 produced by B cells is crucial for the suppression of Th17\/Th1 responses, induction of T regulatory type 1 cells and reduction of collagen-induced arthritis. Arthritis Res Ther. 2012;14:32. https:\/\/doi.org\/10.1186\/ar3736.","journal-title":"Arthritis Res Ther"},{"key":"2725_CR38","doi-asserted-by":"publisher","unstructured":"Hosseini, H. Anti-TIM-1 monoclonal antibody (RMT1-10) attenuates atherosclerosis by expanding IgM-producing B1a cells. J Am Heart Assoc. 2018. https:\/\/doi.org\/10.1161\/JAHA.117.008447.","DOI":"10.1161\/JAHA.117.008447"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02725-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02725-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02725-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T13:27:18Z","timestamp":1759843638000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02725-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,7]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2725"],"URL":"https:\/\/doi.org\/10.1038\/s41420-025-02725-0","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,7]]},"assertion":[{"value":"5 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal experiments were conducted in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals (NIH Publications, No. 8023, revised 1978) and the ARRIVE guidelines. These experiments were approved by the Second Affiliated Hospital of Zhejiang University\u2019s Medical Ethics Committee and Medical Faculty Ethics Committee. Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have consented to the publication of this manuscript here.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"453"}}